In this section, for both control and rd1 we present the grouping case with best outcome, that is high goodness of fit value for [GSH] and for [GSSG]
A subsequent analysis of SELECT trial data presented at the 2025 European Congress on Obesity found that the heart benefits appeared within just a few weeks of starting the medication and were not entirely explained by weight loss alone
p = 0.041) in the whole patient group and a borderline correlation was also observed when looking at the control group only ( r = 0.447, p = 0.053)
(3) Lysosomal Destabilization: CS compromises lysosomal membrane integrity, leading to the leakage of iron ions and hydrolytic enzymes into the cytosol
While Januvia helps regulate blood sugar by indirectly enhancing GLP-1 and GIP, its effects on weight are minimal compared to GLP-1 drugs
GLP-1 receptor agonists, including drugs such as semaglutide, are known to promote weight loss, reduce systemic inflammation, and improve insulin sensitivity, which may collectively contribute to better joint health and reduced disease activity in RA